Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 234

1.

Brain-resident microglia predominate over infiltrating myeloid cells in activation, phagocytosis and interaction with T-lymphocytes in the MPTP mouse model of Parkinson disease.

Depboylu C, Stricker S, Ghobril JP, Oertel WH, Priller J, Höglinger GU.

Exp Neurol. 2012 Dec;238(2):183-91. doi: 10.1016/j.expneurol.2012.08.020.

PMID:
22964486
2.

Evidence for a role of adaptive immune response in the disease pathogenesis of the MPTP mouse model of Parkinson's disease.

Martin HL, Santoro M, Mustafa S, Riedel G, Forrester JV, Teismann P.

Glia. 2016 Mar;64(3):386-95. doi: 10.1002/glia.22935.

3.

Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation.

Moon M, Kim HG, Hwang L, Seo JH, Kim S, Hwang S, Kim S, Lee D, Chung H, Oh MS, Lee KT, Park S.

Neurotox Res. 2009 May;15(4):332-47. doi: 10.1007/s12640-009-9037-x.

PMID:
19384567
4.

Physical activity and environmental enrichment regulate the generation of neural precursors in the adult mouse substantia nigra in a dopamine-dependent manner.

Klaissle P, Lesemann A, Huehnchen P, Hermann A, Storch A, Steiner B.

BMC Neurosci. 2012 Oct 31;13:132. doi: 10.1186/1471-2202-13-132.

6.

Long-lasting reactive changes observed in microglia in the striatal and substantia nigral of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Yasuda Y, Shinagawa R, Yamada M, Mori T, Tateishi N, Fujita S.

Brain Res. 2007 Mar 23;1138:196-202.

PMID:
17275793
7.

Upregulation of microglial C1q expression has no effects on nigrostriatal dopaminergic injury in the MPTP mouse model of Parkinson disease.

Depboylu C, Schorlemmer K, Klietz M, Oertel WH, Weihe E, Höglinger GU, Schäfer MK.

J Neuroimmunol. 2011 Jul;236(1-2):39-46. doi: 10.1016/j.jneuroim.2011.05.006.

PMID:
21640391
8.

Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

Richardson JR, Caudle WM, Guillot TS, Watson JL, Nakamaru-Ogiso E, Seo BB, Sherer TB, Greenamyre JT, Yagi T, Matsuno-Yagi A, Miller GW.

Toxicol Sci. 2007 Jan;95(1):196-204.

9.

SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease.

Ago Y, Kawasaki T, Nashida T, Ota Y, Cong Y, Kitamoto M, Takahashi T, Takuma K, Matsuda T.

Neuropharmacology. 2011 Dec;61(8):1441-51. doi: 10.1016/j.neuropharm.2011.08.041.

PMID:
21903118
10.
11.

Increased host neuronal survival and motor function in BMT Parkinsonian mice: involvement of immunosuppression.

Keshet GI, Tolwani RJ, Trejo A, Kraft P, Doyonnas R, Clayberger C, Weimann JM, Blau HM.

J Comp Neurol. 2007 Oct 20;504(6):690-701.

PMID:
17722033
12.

Bone-marrow-derived cell differentiation into microglia: a study in a progressive mouse model of Parkinson's disease.

Rodriguez M, Alvarez-Erviti L, Blesa FJ, Rodríguez-Oroz MC, Arina A, Melero I, Ramos LI, Obeso JA.

Neurobiol Dis. 2007 Dec;28(3):316-25.

PMID:
17897835
13.

Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease.

Rojo AI, Innamorato NG, Martín-Moreno AM, De Ceballos ML, Yamamoto M, Cuadrado A.

Glia. 2010 Apr;58(5):588-98. doi: 10.1002/glia.20947.

PMID:
19908287
14.

The TrkB-positive dopaminergic neurons are less sensitive to MPTP insult in the substantia nigra of adult C57/BL mice.

Ding YX, Xia Y, Jiao XY, Duan L, Yu J, Wang X, Chen LW.

Neurochem Res. 2011 Oct;36(10):1759-66. doi: 10.1007/s11064-011-0491-5.

PMID:
21562748
15.

Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease.

Viswanath V, Wu Y, Boonplueang R, Chen S, Stevenson FF, Yantiri F, Yang L, Beal MF, Andersen JK.

J Neurosci. 2001 Dec 15;21(24):9519-28.

16.

Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson's disease.

González H, Contreras F, Prado C, Elgueta D, Franz D, Bernales S, Pacheco R.

J Immunol. 2013 May 15;190(10):5048-56. doi: 10.4049/jimmunol.1203121.

17.

Heat shock protein 60: an endogenous inducer of dopaminergic cell death in Parkinson disease.

Noelker C, Morel L, Osterloh A, Alvarez-Fischer D, Lescot T, Breloer M, Gold M, Oertel WH, Henze C, Michel PP, Dodel RC, Lu L, Hirsch EC, Hunot S, Hartmann A.

J Neuroinflammation. 2014 May 8;11:86. doi: 10.1186/1742-2094-11-86.

18.

Estrogen down-regulates glial activation in male mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication.

Tripanichkul W, Sripanichkulchai K, Finkelstein DI.

Brain Res. 2006 Apr 21;1084(1):28-37.

PMID:
16564034
20.

Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra.

Jiang H, Li LJ, Wang J, Xie JX.

Exp Neurol. 2008 Aug;212(2):532-7. doi: 10.1016/j.expneurol.2008.05.006.

PMID:
18577498
Items per page

Supplemental Content

Support Center